Dr. Dipanjan Panda

Dr. Dipanjan Panda is a highly skilled Medical Oncologist currently practicing at Indraprastha Hospital in New Delhi. With more than 15 years of expertise in the field, Dr. Panda has established himself as a reputable professional in the oncology community. His educational background includes an MBBS degree from Calcutta University in 2000 and an MD in General Medicine from Ranchi University in 2005. He completed his specialization in Medical Oncology with a DM degree from the prestigious All India Institute of Medical Sciences, New Delhi in 2010. Dr. Dipanjan Panda has held various positions throughout his career, including Senior Consultant at Indraprastha Apollo Hospital in New Delhi. He has been recognized for his outstanding work and has received several awards and honors. As a junior class assistant, he was declared the top performer in Obstetrics and Gynaecology during his MBBS course. He also received a college scholarship based on his merit during the 8th and 9th semesters of the MBBS program. Additionally, he was awarded the First Certificate of Honour in Medicine and Obstetrics and Gynaecology during his MBBS course. Dr. Panda's areas of interest and expertise include the treatment of gastrointestinal and hepatic pancreatic and biliary malignancies, breast and gynecological malignancies, lung and head-neck cancers, genitourinary malignancies, lymphomas, myelomas, and rare tumors like neuroendocrine tumors. He is an active member of prominent professional organizations such as the European Society of Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO). Dr. Panda has been invited as an expert member to various meetings and advisory committees related to oncology, including the INASL task force on Hepatocellular Carcinoma and the advisory committee meeting on HCC of Bayer Oncology. Dr. Dipanjan Panda has also contributed significantly to research in the field of oncology, with several published papers in renowned medical journals. His research focuses on various topics, including metastases to the kidneys in oral squamous cell carcinoma, catheter-associated mycobacteremia, supportive care for terminal-stage hepatocellular carcinoma, and the role of surveillance in the prevention of hepatocellular carcinoma. With his extensive experience, expertise, and dedication to advancing the field of oncology, Dr. Dipanjan Panda is committed to providing the best possible care to his patients and making a positive impact in the fight against cancer.